ARS Pharmaceuticals, Inc (SPRY) — Defensive Interval Ratio
ARS Pharmaceuticals, Inc (SPRY) has a Defensive Interval Ratio of 2135 days as of December 2025. Defensive assets of $229.02 Million (cash $-, short-term investments $203.67 Million, receivables $25.35 Million) cover 2135 days of daily cash needs of $107.25K/day. See ARS Pharmaceuticals, Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ARS Pharmaceuticals, Inc Defensive Interval Ratio (2020–2025)
This chart shows how ARS Pharmaceuticals, Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 2135 days, meaning defensive assets of $229.02 Million can fund 2135 days of operations without new revenue. See SPRY equity to assets ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for ARS Pharmaceuticals, Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for ARS Pharmaceuticals, Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see SPRY market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2135 days | $229.02 Million | $107.25K/day | $- | $203.67 Million | ▼ -2106 days |
| 2024 | 4241 days | $272.37 Million | $64.22K/day | $- | $263.20 Million | ▼ -19906 days |
| 2023 | 24148 days | $158.18 Million | $6.55K/day | $- | $157.39 Million | ▲ +19798 days |
| 2022 | 4349 days | $64.87 Million | $14.92K/day | $- | $63.86 Million | ▲ +4349 days |
| 2021 | 0 days | $1.00K | $22.43K/day | $- | $0.00 | ▼ -17 days |
| 2020 | 17 days | $384.00K | $22.49K/day | $- | $- | — |